As of 2025-09-17, the Relative Valuation of Jounce Therapeutics Inc (JNCE) is (8.88) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.88 USD, the upside of Jounce Therapeutics Inc based on Relative Valuation is -572.1%.
The range of the Relative Valuation is (9.67) - (6.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 6.4x - 6.7x | 6.6x |
| Forward P/E multiples | 10.0x - 13.6x | 11.8x |
| Fair Price | (9.67) - (6.48) | (8.88) |
| Upside | -614.6% - -444.8% | -572.1% |
| Date | P/E |